the effect of dose reduction of talquetamab in patients with r/r mm: results from monumental-1
Published 7 months ago • 128 plays • Length 2:34Download video MP4
Download video MP3
Similar videos
-
0:50
dose modifications of talquetamab to manage aes in patients with multiple myeloma
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:20
the effect of ibrutinib dose-reduction on outcomes of patients with cll/sll: real-world evidence
-
2:02
rwd from insight-mm: duration of therapy and treatment sequencing
-
1:33
sequencing and the management of adverse events when administering bispecifics for myeloma
-
2:36
a cd38-targeting bispecific antibody in the treatment of r/r t-all
-
0:43
elm-2: qol and orr outcomes of odronextamab treatment for r/r fl
-
1:46:07
hematology lecture
-
9:25
mgus diagnosis: a step-by-step approach
-
3:52
blood volume monitoring animation - crit-line® technology
-
1:17
phase ii study of tosedostat in mds
-
2:58
bcma 2 1 t-cell engager cc-93269 in patients with r/r myeloma
-
3:17
locommotion: analysis of soc for r/r myeloma
-
5:07
daratumumab in the management of al amyloidosis
-
2:04
state-of-the-art treatment for hr-mds
-
0:57
the potential of the tsafinder tool in hematological oncology
-
0:53
go-flag: bridge therapy to allo-sct in r/r aml
-
0:52
tocilizumab for aa amyloidosis
-
1:21
the correlation between jak2v617f molecular response and efs in patients with early pv
-
2:43
gemtuzumab ozogamicin in frontline aml therapy
-
2:41
an overview of the latest advances in hematology